12:00 AM
 | 
Oct 12, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

BvdU: Phase II discontinued

SciClone discontinued a double-blind, placebo-controlled Phase II trial based on the recommendation of an independent DSMC. The company said it is "disappointed with the discontinuation of this study" and it will provide further details when the data...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >